| |
| |
|
| Insider
Information: |
Oren Ilan |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
80,409 |
|
|
Indirect Shares
|
75,000,000 |
|
|
| Direct
Value |
$901,385 |
|
|
|
Indirect Value
|
$35,850,000 |
|
|
| Total
Shares |
75,080,409 |
|
|
| Total
Value |
$36,751,385 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sio Gene Therapies Inc |
SIOX |
Director, 10% Owner |
|
0 |
2015-06-10 |
75,000,000 |
Premium* |
|
|
Roivant Sciences Ltd. |
ROIV |
|
2024-04-24 |
80,409 |
2022-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2024-04-24 |
4 |
D |
$10.90 |
$589 |
D/D |
(54) |
80,409 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2024-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,121 |
80,463 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2024-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,366 |
78,342 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,269 |
74,976 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-09-18 |
4 |
AS |
$11.17 |
$97,213 |
D/D |
(8,703) |
72,707 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
17,825 |
81,410 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,472 |
63,585 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,942 |
62,113 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,010 |
60,171 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2022-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,796 |
58,161 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
52,142 |
55,365 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
Director |
– • – |
2022-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,223 |
3,223 |
0 |
- |
|
| SIOX |
Sio Gene Therapies Inc |
Director |
– • • |
2015-06-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
75,000,000 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
